Over 2,000 Atlantans flock to Central Park for second annual Sharecare Heartbeat Festival

Sharecare

Fulton County Board of Commissioners declares “Sharecare Day” at family-friendly festival aimed at helping people live happier, healthier lives ATLANTA, April 17, 2019 (GLOBE NEWSWIRE) — On Saturday, April 13, 2019, more than 2,000 people gathered in Central Park in Atlanta’s Old Fourth Ward neighborhood for the second annual Sharecare Heartbeat Festival, a free, family-friendly event that provides a range…

Read More

Pivot Pharmaceuticals, Inc. (CSE: PVOT) (OTCQB: PVOTF) Surges 45% After Signing LOI with Pharmascience, Inc.

Pivot Pharmaceuticals, Inc.

Pivot Pharmaceuticals, Inc. (CSE: PVOT) (OTCQB: PVOTF) is a biopharmaceutical company focused on the development and commercialization of cannabis-based therapeutic pharmaceuticals, nutraceuticals, and drug delivery platform technologies. The company’s U.S.-listed shares surged 44.79% on Wednesday, April 3, 2019. Over the past month, Pivot has seen an average daily volume of 24,550 shares. However, on Wednesday, 239,787 shares traded hands, equating…

Read More

Scholar Rock Presents Additional Preclinical Data Demonstrating a Highly Specific Inhibitor of TGFβ1 Activation Can Render Resistant Solid Tumors Vulnerable to PD1 Blockade and Drive Tumor Regression with Combination Therapy

Scholar Rock Holding Corporation

Preclinical data presented at the American Association for Cancer Research annual meeting provide further support for the potential of SRK-181 to overcome primary resistance to checkpoint blockade therapy (CBT) TGFβ1-specific inhibition by SRK-181-mIgG1 was sufficient to render both TGFβ1-expressing and TGFβ1/TGFβ3 co-expressing mouse tumor models sensitive to anti-PD1 immunotherapy, suggesting TGFβ1 is the key isoform contributing to CBT resistance Combination…

Read More

HEALTHE® INTRODUCES THE FIRST DYNAMIC CIRCADIAN A19

HEALTHE

The New SunTrac™ A19 Seamlessly Transitions Between GoodDay® and GoodNight® Spectrums Cocoa Beach, FL, March 29, 2019 (GLOBE NEWSWIRE) — Healthe® is excited to announce the launch of SunTrac™ A19, a product that combines engineered spectrums that have been optimized for both daytime and nighttime use into a single, dynamic, circadian lamp. Based on market demand, Healthe combined its proprietary…

Read More

Resverlogix Announces Ninth Positive Data Safety Monitoring Board Recommendation for Phase 3 Study of Apabetalone

Resverlogix Corp.

BETonMACE trial to continue as planned without modification CALGARY, Alberta, March 27, 2019 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) today announces the independent Data and Safety Monitoring Board (DSMB) has completed a ninth planned safety review for the Company’s Phase 3, BETonMACE trial for high-risk cardiovascular disease patients and recommended the study continue without modification. The…

Read More

CurvaFix Receives FDA 510(k) Clearance for CurvaFix Rodscrew Company’s Innovative Curved Device to aid Orthopedic Trauma Surgery

CurvaFix

BELLEVUE, Wash., March 05, 2019 (GLOBE NEWSWIRE) — CurvaFix, Inc., a developer of medical devices to repair bone fractures in orthopedic trauma patients, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the CurvaFix® Intramedullary Rodscrew. CurvaFix’s patented solution has the potential to improve outcomes and enable a less invasive approach in…

Read More

Vystar Debuts Enhanced RxAir® UV Light Air Purifiers to Fight Flu, Colds & Airborne Germs

Vystar Corp.

WORCESTER, Mass., Jan. 28, 2019 (GLOBE NEWSWIRE) — Vystar Corp. (OTC Market: VYST) announced today that new and improved RxAir® UV Light Air Purifiers are now available to combat cold, flu and other airborne germs that are more pervasive during the winter.  Vystar acquired RxAir approximately nine months ago and immediately began upgrading the air purifiers to improve performance and…

Read More

CORRECTING and REPLACING – Aurora Spine Announces New Patent for Its Minimally Invasive Spinal Implants Allowed by the United States Patent Office

Aurora Spine Corporation

CARLSBAD, Calif., Jan. 23, 2019 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Aurora Spine Corporation (TSXV: ASG) please note that “Expendable Interspinous Device” has been changed to “Expandable Interspinous Device” in the first paragraph. The corrected release follows: Aurora Spine Corporation (TSXV: ASG) announced today the issuance by the United States Patent and Trademark Office (USPTO) of United States…

Read More

New report: Are prescriptions contributing to the opioid crisis? Canadians are taking increased doses despite national guidelines

Reformulary Group

TORONTO, Jan. 22, 2019 (GLOBE NEWSWIRE) — Reformulary Group, a Canadian healthcare technology company, today released a report on opioid prescribing in Canada. The report analyzes the data of over six million prescription Canadians that submitted a drug claim from 2013 to 2017 to address the impact of prescription opioids on the health and safety of all Canadians. The report,…

Read More

Q BioMed Announces Strategic Partnership with SRI International for Formulation and Preclinical Development of QBM-001 for Pediatric Nonverbal Disorder in Autistic Children

Collaboration with SRI Provides QBioMed Expertise in Formulation Development and Preclinical Work in Autism, as well as CMC and Manufacturing capability NEW YORK, December 12, 2018 — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, is pleased to announce a collaborative agreement with SRI International to provide formulation development, preclinical development, and early clinical manufacturing of QBM-001, in support…

Read More